Copyright
©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1127-1139
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1127
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1127
Figure 1 Selection of patient cohorts.
1In total, 135 patients had only one outpatient alterations in plasma protein metabolism (APPM) diagnosis and therefore did not meet these criteria; 2In total, 42 patients with fibrosis in the APPM cohort progressed to cirrhosis during follow-up; and 3In total, 280 patients with fibrosis in the control cohort progressed to cirrhosis during follow-up. ICD-10-GM: German Modification of the International Classification of Diseases-10th Revision.
Figure 2 Disease progression events.
Disease progression events that occurred after the index date until the end of the study. APPM: Alterations in plasma protein metabolism.
Figure 3 Event-free survival for disease progression events in patients with cirrhosis with and without alterations in plasma protein metabolism.
A: Ascites; B: Hepatic failure; C: Esophageal and gastric varices; D: Hepatic encephalopathy. APPM: Alterations in plasma protein metabolism; CI: Confidence interval; NR: Not reached.
Figure 4 Survival in patients with fibrosis and cirrhosis.
A: Fibrosis; B: Cirrhosis. APPM: Alterations in plasma protein metabolism; CI: Confidence interval; NR: Not reached.
- Citation: Picker N, Hagiwara M, Baumann S, Marins EG, Wilke T, Ren K, Maywald U, Karki C, Strnad P. Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis. World J Hepatol 2023; 15(10): 1127-1139
- URL: https://www.wjgnet.com/1948-5182/full/v15/i10/1127.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i10.1127